GB-0895

DRUG4 trials

Sponsors

Generate Biomedicines Inc., Generate Biomedicines

Conditions

Severe AsthmaSevere uncontrolled asthmasevere uncontrolled asthma

Phase 3

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

RecruitingNCT07276724

Generate BiomedicinesSevere Asthma

Start: 2025-12-03End: 2028-12-01Target: 786Updated: 2026-09-08

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

RecruitingNCT07359846

Generate BiomedicinesSevere Asthma

Start: 2026-01-20End: 2029-01-01Target: 786Updated: 2026-09-08

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma

Not yet recruitingCTIS2025-521950-41-00

Generate Biomedicines Inc.severe uncontrolled asthma

Target: 122Updated: 2026-05-13

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma

Not yet recruitingCTIS2025-524040-35-00

Generate Biomedicines Inc.Severe uncontrolled asthma

Target: 57Updated: 2026-05-27